Navigation Links
OxyBand Technologies Signs Army Contract
Date:5/9/2008

SAN FRANCISCO, May 9 /PRNewswire/ -- OxyBand Technologies, Inc. today announced that it has signed a contract with the United States Army to evaluate the company's patented cutting edge wound healing technology for battlefield and other military wounds. OxyBand Technologies has developed a proprietary wound dressing that delivers pure oxygen gas into wounds for faster healing. The OxyBand dressing has been shown in clinical trials to accelerate healing and, in laboratory testing, to reduce bacteria for infection. The OxyBand Wound Dressing has received FDA 510(k) clearance for both prescription (Rx) and over the counter (OTC) marketing.

"This initial contract with the Army establishes a great position for OxyBand to further demonstrate the OxyBand wound healing prowess and moves us closer to our goal of providing a real benefit to the men and women defending our country," said Dr. Amie Franklin, CEO of OxyBand Technologies.

OxyBand Technologies has developed a proprietary technology for packaging pure oxygen into a discrete wound dressing using directionally permeable gas- emitting reservoirs. The resulting dressing has been shown in randomized, controlled double-blind trials to significantly accelerate wound healing, reduce inflammation, redness and pain through the direct and sustained application of pure oxygen over several days.

Funding under this new Army contract is for an evaluation of OxyBand dressings for accelerated healing of battlefield and other wounds, which is of concern to the U.S. military. OxyBand anticipates beginning work under the contract with the United States Army Medical Research and Material Command (USAMRMC) immediately. The clinical study evaluating OxyBand Dressings will be conducted at the United States Army Institute for Surgical Research, (USAISR) which is a part of the USAMRMC and is co-located with Brooke Army Medical Center.

"As part of our overall program to improve the care given to wounded mili
'/>"/>

SOURCE OxyBand Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ewswire/ -- The Pew Charitable Trusts announced to...emical and food safety programs, in its Health &am...ormerly deputy staff director and general counsel ...Works, brings nearly 25 years of experience in env..., , "We are excited to be joined by such an expe...
(Date:1/8/2009)...rstCall/ -- Cephalon, Inc . (Nasdaq: CEPH ) tod...man and CEO will present at the J.P. Morgan Healt...n San Francisco, CA at approximately 4:00 p.m. Pac...will be webcast live on the investor relations sec... will be archived for one week following the broad...
(Date:1/8/2009)...e-FirstCall/ -- Heska Corporation (Nasdaq: HSKA ...hat: Heska Corporation Invites You to Join Its...arnings Conference Call on the Web, When: ...Where: www.heska.com (click on the Q4 and Year-...front page of this website)., How: Live...
(Date:1/8/2009)...wire/ -- St. Jude Children,s Research,Hospital(R)...Cup Runner-Up,Camilo Villegas has increased his c... match Singh,s donation of $5,000 to St. Jude for ...s for St. Jude is a powerful program that,has uni...sing LPGA star Morgan,Pressel, along with the Gol...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...o latest research , sudden emotional stress can re...s that mimics a classic heart attack.// Stress ca...sive heart attack. According to the researchers, p...rge in adrenalin and other stress hormones that te...
...ndings of a recent study researchers say , cancer ...us thrombosis, // or blood clots in the legs or lu...o 70, who had a blood clot in their legs or lungs....he presence of distant metastases, and carrier sta...
...world congress for diabetes begins in Chennai toda...betes and its complications //and over 1000 doctor...untries across the world. The world congress for...very three years, since the time of its inception ...
...tion therapy is used to treat deep vein thrombosis...is or arms. Researchers say several new studies sh...plify anticoagulation therapy.// In the first stu...hrombosis) patients and compared the effectiveness...
Other Medicine News:
(Date:1/7/2009)...PRNewswire/ -- ImQuest Life Sciences announced tod... to the Food and Drug Administration to initiate h...e HIV inhibitor IQP-0410. ImQuest anticipates init...of 2009. IQP-0410 is a novel small molecule inhibi... reverse transcriptase inhibitor (NNRTI). The comp...
(Date:1/7/2009)...uary 7 Circassia Ltd, a specialty,...critical care, today,announced that following suc...s ToleroMune(R) anti-allergy technology, the compa...rther phase II clinical trial in cat allergy. The,... 120 patients with confirmed,cat allergies, and a...
(Date:1/6/2009)...RNewswire/ -- In recent controlled studies conduct..., scientists found that the patented ingredient in...y proven ingredient to increase levels of nitric o...trate/nitrate (NOx) in human subjects. , , Nitr...ease in blood flow to the skeletal muscles. This ...
(Date:1/6/2009)... Cequent Pharmaceuticals, a pionee...RNAi-based treatments to prevent and treat human d...mpleted a successful toxicology study of its candi...peutic targeting the primary oncogene (beta-cateni.... FAP is an inherited gastrointestinal disease tha...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 1Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 2Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 3China Medicine Releases White Paper on Developing Recombinant Aflatoxin Detoxifizyme 23558 1China Medicine Releases White Paper on Developing Recombinant Aflatoxin Detoxifizyme 23558 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 1Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 3Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 1Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 2Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 3Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 4
...ETROIT, April 16, 2007 /PRNewswire/ -- Karmanos Ca... on two research,studies investigating racial disp... American Association of Cancer Research,annual me...h endometrial or ovarian cancer, on,average, live ...ed,by Veronica Schimp, D.O., assistant professor o...
...nespimycin Shown to Have No Effect on QTc Interval...Kosan,Biosciences Incorporated today presented saf...its lead Hsp90 inhibitor,tanespimycin (KOS-953). ...nts was conducted in four Phase 1 trials of tanesp... in more than 85,patients. Tanespimycin was found ...
Other Medicine Technology:Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 2Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: